CHMP5 and viral infectious disease: NCOA7 inhibited wild-type virus infection by ~6-fold (Fig 5A and 5C), whereas infection with ΔPRRA Spike bearing virus was inhibited by ~3-fold (Fig 5B and 5C), an ~50% decrease in NCOA7 sensitivity.